Cibus’ (CBUS) Buy Rating Reaffirmed at HC Wainwright

Cibus (NASDAQ:CBUS)‘s stock had its “buy” rating restated by research analysts at HC Wainwright in a research report issued to clients and investors on Friday,Benzinga reports. They currently have a $25.00 price objective on the stock.

Separately, Canaccord Genuity Group decreased their price target on shares of Cibus from $20.00 to $18.00 and set a “buy” rating for the company in a report on Wednesday, January 22nd.

Cibus Price Performance

Cibus stock opened at $2.19 on Friday. The firm’s 50 day simple moving average is $2.34 and its 200-day simple moving average is $3.38. The company has a market cap of $57.94 million, a P/E ratio of -0.10 and a beta of 2.04. Cibus has a fifty-two week low of $1.80 and a fifty-two week high of $23.18.

Cibus (NASDAQ:CBUS) last released its earnings results on Thursday, March 20th. The company reported ($0.87) earnings per share for the quarter, missing the consensus estimate of ($0.68) by ($0.19). The firm had revenue of $1.21 million during the quarter, compared to analysts’ expectations of $1.13 million. Cibus had a negative return on equity of 28.17% and a negative net margin of 10,724.78%. On average, analysts expect that Cibus will post -2.96 EPS for the current fiscal year.

Institutional Trading of Cibus

Several institutional investors have recently made changes to their positions in CBUS. FMR LLC lifted its stake in Cibus by 16.9% in the third quarter. FMR LLC now owns 3,913,279 shares of the company’s stock valued at $12,757,000 after acquiring an additional 566,328 shares during the last quarter. Granby Capital Management LLC lifted its stake in Cibus by 300.0% in the fourth quarter. Granby Capital Management LLC now owns 200,000 shares of the company’s stock valued at $556,000 after acquiring an additional 150,000 shares during the last quarter. Renaissance Technologies LLC lifted its stake in Cibus by 933.3% in the fourth quarter. Renaissance Technologies LLC now owns 127,100 shares of the company’s stock valued at $353,000 after acquiring an additional 114,800 shares during the last quarter. State Street Corp lifted its stake in Cibus by 43.6% in the third quarter. State Street Corp now owns 307,262 shares of the company’s stock valued at $1,002,000 after acquiring an additional 93,236 shares during the last quarter. Finally, Certior Financial Group LLC acquired a new stake in Cibus in the fourth quarter valued at approximately $236,000. 33.81% of the stock is currently owned by institutional investors and hedge funds.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.